BioSpace News Archive

Gossamer Bio, Inc. today announced topline results for the TORREY Phase 2 study of seralutinib in patients with pulmonary arterial hypertension (PAH).

Entact Bio today announced it has raised $81 million in Series A financing to advance its proprietary Encompass™ platform for developing enhancement-targeting chimeric (ENTAC™) molecules.

BiondVax Pharmaceuticals Ltd. today announced that Professor Dr. med. Matthias Dobbelstein has been appointed a member of the company’s Scientific Advisory Board (SAB).

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced a definitive agreement of its partnership with Akeso Inc. (HKEX Code: 9926.HK, “Akeso”), to in-license its breakthrough bispecific antibody, ivonescimab.

Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2) announced today that a clinical study conducted by its wholly owned subsidiary KGK Science Inc. (“KGK”), has shown positive results of UP446 supplementation in helping mount a robust immune response following influenza vaccination.

EDAP TMS SA, the global leader in robotic energy-based therapies, announced that the Company has hired medical capital equipment finance industry veteran Ken Mobeck as Chief Financial Officer of EDAP Technomed Inc., the Company’s U.S. subsidiary.

Saint-Herblain, December06, 2022 – Valneva SE, a specialty vaccine company, is hosting an in-person investor day in New York City to discuss the Company’s current vaccine pipeline, commercial products, and future directions.

Spago Nanomedical AB announced that the company has received regulatory approval to initiate a Phase IIa clinical study with its MRI contrast agent SN132D in endometriosis - a chronic, debilitating condition that affects up to 10 percent of women of reproductive age.

ADAMA Ltd., a leading global crop protection company, announced the acquisition of AgriNova New Zealand, Ltd – known as Grochem New Zealand.

Natera, Inc., a global leader in cell-free DNA testing, announced the publication in Prenatal Diagnosis of a clinical experience study in twin pregnancies featuring its Panorama single nucleotide polymorphism -based noninvasive prenatal test.